The Prognostic Impact of Tumor Microenvironment and Checkpoint Blockade-Associated Molecules (PD-1, PD-L1, CD163 and CD14) in Nodal Diffuse Large B-cell Lymphoma, NOS-Reference-Cited by-同舟云学术

The Prognostic Impact of Tumor Microenvironment and Checkpoint Blockade-Associated Molecules (PD-1, PD-L1, CD163 and CD14) in Nodal Diffuse Large B-cell Lymphoma, NOS

Published:2023-05-11 Issue: Volume: Page:
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Atmış Ömer^ORCID,Neşe Nalan^ORCID,Aydoğdu İsmet^ORCID,Alaca İlknur^ORCID,Mavili Hanife Seda^ORCID,İşisağ Aydın^ORCID

Funder

Manisa Celal Bayar Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12288-023-01667-w.pdf

Reference20 articles.

1. Wang J, Gao K, Lei W, Dong L, Xuan Q, Feng M et al (2017) Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes. Oncotarget 8(3):5414–5425. https://doi.org/10.18632/oncotarget.14289

2. Hunt KE, Reichard KK (2008) Diffuse large B-cell lymphoma. Arch Pathol Lab Med 132(1):118–124. https://doi.org/10.5858/2008-132-118-DLBL

3. Zhou S, Xu L, Ma Y, Tang L, Zhang Y, Shi Y et al (2017) Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma. Oncotarget 8(12):19556–19565. https://doi.org/10.18632/oncotarget.14700

4. Bairey O, Shacham-Abulafia A, Shpilberg O, Gurion R (2016) Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematol Oncol 34(4):184–192. https://doi.org/10.1002/hon.2233

5. Wang S, Ma Y, Sun L, Shi Y, Jiang S, Yu K et al (2018) Prognostic significance of pretreatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with diffuse large B-Cell lymphoma. Biomed Res Int 2018:9651254. https://doi.org/10.1155/2018/9651254